Literature DB >> 30458125

Simplified LC/MS assay for the measurement of isolevuglandin protein adducts in plasma and tissue samples.

Valery N Yermalitsky1, Elena Matafonova1, Keri Tallman2, Zhuoheng Li1, William Zackert1, L Jackson Roberts1, Venkataraman Amarnath1, Sean S Davies3.   

Abstract

Isolevuglandins (IsoLGs) are a family of highly reactive 4-ketoaldehydes formed by lipid peroxidation that modify the lysyl residues of cellular proteins. Modification of proteins by IsoLGs have been shown to contribute to disease processes such as the development of hypertension. Accurate quantitation of the extent of protein modification by IsoLGs is essential for understanding the mechanisms whereby these modifications contribute to disease and the efficacy of interventions designed to prevent this modification. The previously described LC/MS assay to quantitate IsoLG protein adducts was extremely labor-intensive and time consuming, and while it offered reasonably low intra-day variation for replicate samples, variation when replicate samples were processed on separate days was significant. These limitations significantly restricted utilization of this approach. We therefore performed a series of studies to optimize the assay. We now report a significantly simplified LC/MS assay for measurement of IsoLG protein adducts with increased sensitivity and lower intra-day and inter-day variability.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Aldehydes; Isolevuglandins; LC/MS; Lipid peroxidation; Post-translational modifications; Protein adducts

Mesh:

Substances:

Year:  2018        PMID: 30458125     DOI: 10.1016/j.ab.2018.11.007

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  5 in total

Review 1.  Isolevuglandins as mediators of disease and the development of dicarbonyl scavengers as pharmaceutical interventions.

Authors:  Sean S Davies; Linda S May-Zhang; Olivier Boutaud; Venkataraman Amarnath; Annet Kirabo; David G Harrison
Journal:  Pharmacol Ther       Date:  2019-10-16       Impact factor: 12.310

2.  Kidney injury-mediated disruption of intestinal lymphatics involves dicarbonyl-modified lipoproteins.

Authors:  Jianyong Zhong; Hai-Chun Yang; Valery Yermalitsky; Elaine L Shelton; Tadashi Otsuka; Carrie B Wiese; Linda S May-Zhang; Babak Banan; Naji Abumrad; Jiansheng Huang; Ashley B Cavnar; Annet Kirabo; Patricia G Yancey; Agnes B Fogo; Kasey C Vickers; MacRae F Linton; Sean S Davies; Valentina Kon
Journal:  Kidney Int       Date:  2021-06-05       Impact factor: 18.998

3.  Isolevuglandins disrupt PU.1-mediated C1q expression and promote autoimmunity and hypertension in systemic lupus erythematosus.

Authors:  David M Patrick; Néstor de la Visitación; Jaya Krishnan; Wei Chen; Michelle J Ormseth; C Michael Stein; Sean S Davies; Venkataraman Amarnath; Leslie J Crofford; Jonathan M Williams; Shilin Zhao; Charles D Smart; Sergey Dikalov; Anna Dikalova; Liang Xiao; Justin P Van Beusecum; Mingfang Ao; Agnes B Fogo; Annet Kirabo; David G Harrison
Journal:  JCI Insight       Date:  2022-07-08

4.  Modified sites and functional consequences of 4-oxo-2-nonenal adducts in HDL that are elevated in familial hypercholesterolemia.

Authors:  Linda S May-Zhang; Valery Yermalitsky; John T Melchior; Jamie Morris; Keri A Tallman; Mark S Borja; Tiffany Pleasent; Venkataraman Amarnath; Wenliang Song; Patricia G Yancey; W Sean Davidson; MacRae F Linton; Sean S Davies
Journal:  J Biol Chem       Date:  2019-10-30       Impact factor: 5.486

5.  Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr-/- mice.

Authors:  Huan Tao; Jiansheng Huang; Patricia G Yancey; Valery Yermalitsky; John L Blakemore; Youmin Zhang; Lei Ding; Irene Zagol-Ikapitte; Fei Ye; Venkataraman Amarnath; Olivier Boutaud; John A Oates; L Jackson Roberts; Sean S Davies; MacRae F Linton
Journal:  Nat Commun       Date:  2020-08-14       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.